Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 16,320 shares at $89.17 ($1.5M) on 2024-10-31, disclosed to the SEC on 2024-11-04.
Scheduled sale ($1.5M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.25 | 1,980 | $175K | 12.0% |
| 2 | $89.17 | 6,320 | $564K | 38.7% |
| 3 | $89.17 | 6,320 | $564K | 38.7% |
| 4 | $90.31 | 1,600 | $144K | 9.9% |
| 5 | $90.94 | 100 | $9K | 0.6% |
| Total | $89.18 avg | 16,320 |
| $1.5M |
| 100% |
| Filing → |
| NUVL | SELL | 2026-05-05 | $1.1M | — | Filing → |
| NUVL | SELL | 2026-04-03 | $1.2M | — | Filing → |
| NUVL | SELL | 2026-03-26 | $2.5M | — | Filing → |